Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
Kahealani Uehara, Jaimarie Sostre‐Colón, Matthew Gavin, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 13, Iss. 6, pp. 1625-1647
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling
Kaixin Ding, Zhipeng Zhang, Zhengbin Han, et al.
Science (2025) Vol. 387, Iss. 6737
Closed Access | Times Cited: 3
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez–Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Neha Bhat, Arya Mani
Nutrients (2023) Vol. 15, Iss. 10, pp. 2323-2323
Open Access | Times Cited: 31
Insulin Regulation of Hepatic Lipid Homeostasis
Kahealani Uehara, Dominic Santoleri, Anna E. Garcia Whitlock, et al.
Comprehensive physiology (2023), pp. 4785-4809
Open Access | Times Cited: 29
Metabolic-Dysfunction Associated Steatotic Liver Disease -Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Ideal Treatments
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2023)
Open Access | Times Cited: 26
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 14
Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease
Fubiao Shi, Sheila Collins
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11497-11497
Open Access | Times Cited: 23
Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis
Xiaojuan Chao, Shaogui Wang, Xiaowen Ma, et al.
Hepatology (2023) Vol. 78, Iss. 2, pp. 503-517
Closed Access | Times Cited: 17
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 8
Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
S. Niranjan, Brett E. Phillips, Nick Giannoukakis
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease
Robert Win Maw Min, Filbert W.M. Aung, Bryant Liu, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2035-2035
Open Access | Times Cited: 17
The effects and mechanisms of Xiaoyao San on nonalcoholic fatty liver disease rat based on transcriptomics and proteomics analysis
Yunxiao Liu, Shuanghu Wang, Ayesha Younas, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Tea Polysaccharide Ameliorates Atherosclerosis by Inhibiting Insulin Resistance-Mediated Hepatic VLDL Overproduction
Dan-Dan Kuang, Ting Zhang, Xiaoyu Guo, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
S-Adenosylmethionine Deficit Disrupts Very Low-Density Lipoprotein Metabolism Promoting Liver Lipid Accumulation in Mice
María R Luque-Urbano, David Fernández‐Ramos, Fernando Lopitz‐Otsoa, et al.
Journal of Lipid Research (2025), pp. 100794-100794
Open Access
Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity
Hiroshi Tsuneki, Takahiro Maeda, Shinjiro Takata, et al.
Cell Reports (2022) Vol. 41, Iss. 3, pp. 111497-111497
Open Access | Times Cited: 15
PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer
Min Zhu, Yunguan Wang, Tianshi Lü, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1711-1725.e8
Closed Access | Times Cited: 3
Dysfunctional VLDL metabolism in MASLD
Urko M. Marigorta, Óscar Millet, Shelly C. Lu, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors
Nutan Sharma, Lakhwinder Singh, Aditya Sharma, et al.
Pharmacological Research (2024) Vol. 208, pp. 107375-107375
Open Access | Times Cited: 3
Targeting ketone body metabolism to treat fatty liver disease
Sora Kwon, Reshani Jeyaratnam, Kyoung-Han Kim
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access | Times Cited: 3
mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b
Kahealani Uehara, Won Dong Lee, Megan Stefkovich, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 2
Pharmacological effects of mTORC1/C2 inhibitor in a preclinical model of NASH progression
Mahak Arora, Zuzana Pavlíková, Tomáš Kučera, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115447-115447
Open Access | Times Cited: 4
Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment
Viktoriia Iakovleva, Anna Wuestefeld, Agnes Bee Leng Ong, et al.
npj Regenerative Medicine (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Prevalence of Liver Steatosis in Tuberous Sclerosis Complex Patients: A Retrospective Cross-Sectional Study
Thaïs De Bock, Carola Brussaard, Silke François, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2888-2888
Open Access | Times Cited: 1
ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation
Danli Kong, Zhenhua Mai, Yongze Chen, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1526-1526
Open Access | Times Cited: 6
Insulin Regulation of Hepatic Lipid Homeostasis
Kahealani Uehara, Dominic Santoleri, Anna E. Garcia Whitlock, et al.
Comprehensive physiology (2023) Vol. 13, Iss. 3, pp. 4785-4809
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top